Compare HTCR & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | CELZ |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 6.6M |
| IPO Year | 2022 | 2008 |
| Metric | HTCR | CELZ |
|---|---|---|
| Price | $0.23 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 408.9K | 15.6K |
| Earning Date | 03-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 57.73% | N/A |
| EPS Growth | ★ 66.67 | 32.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,407,229.00 | $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.19 | N/A |
| 52 Week Low | $0.22 | $1.50 |
| 52 Week High | $1.66 | $6.25 |
| Indicator | HTCR | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.86 | 42.41 |
| Support Level | $0.22 | $1.72 |
| Resistance Level | $0.26 | $1.99 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 13.74 | 17.39 |
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.